breast cancer

You have access
The Impact of Insulin on Low-dose Metronomic Vinorelbine and Mafosfamide in Breast Cancer Cells
SLAVOMIR KRAJNAK, AMELIE LOEWE, MARCO JOHANNES BATTISTA, ANNETTE HASENBURG, ANNE-SOPHIE HEIMES, MARCUS SCHMIDT, ROXANA SCHWAB and WALBURGIS BRENNER

Anticancer Research March 2021, 41 (3) 1243-1250; DOI: https://doi.org/10.21873/anticanres.14881
You have access
Anatomical Predictors of Dosimetric Advantages for Deep-inspiration-breath-hold 3D-conformal Radiotherapy Among Women With Left Breast Cancer
GIANLUCA FERINI, LAURA MOLINO, ANTONELLA TRIPOLI, VITO VALENTI, SALVATORE IVAN ILLARI, VALENTINA ANNA MARCHESE, IRENE RITA CRAVAGNO and GIUSEPPINA RITA BORZI

Anticancer Research March 2021, 41 (3) 1529-1538; DOI: https://doi.org/10.21873/anticanres.14912
You have access
Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: The JONIE1 Study
AKIMITSU YAMADA, KYOKO NAKAZAWA, KOHEI AKAZAWA, KAZUTAKA NARUI, ITARU ENDO, YOSHIE HASEGAWA, NORIO KOHNO, TAKASHI ISHIKAWA and THE JONIE STUDY GROUP

Anticancer Research February 2021, 41 (2) 1063-1068; DOI: https://doi.org/10.21873/anticanres.14863
You have access
Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade
RASHIDRA R. WALKER, KAREN M. GALLEGOS, MELYSSA R. BRATTON, KITANI P. LEMIEUX, KUN ZHANG, GUANGDI WANG, A. MICHAEL DAVIDSON and SYREETA L. TILGHMAN

Anticancer Research February 2021, 41 (2) 583-599; DOI: https://doi.org/10.21873/anticanres.14810
You have access
Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients
MARIA A. PAPADAKI, DESPOINA AGGOURAKI, ELENI-KYRIAKI VETSIKA, NIKOLAOS XENIDIS, GALAKTEA KALLERGI, ATHANASIOS KOTSAKIS and VASSILIS GEORGOULIAS

Anticancer Research February 2021, 41 (2) 661-670; DOI: https://doi.org/10.21873/anticanres.14817
You have access
Immunohistochemical Assessment of TNFAIP3/A20 Expression Correlates With Early Tumorigenesis in Breast Cancer
FATEMEH SAHEB SHARIF-ASKARI, NOURA AL-KHAYYAL, IMAN TALAAT, NARJES SAHEB SHARIF-ASKARI, SURENDRA RAWAT, MAJD JUNDI, KARI SYRJÄNEN, RIFAT HAMOUDI and RIYAD BENDARDAF

Anticancer Research February 2021, 41 (2) 739-745; DOI: https://doi.org/10.21873/anticanres.14825
You have access
Chloride Intracellular Channel Protein 1 (CLIC1), E-cadherin and P-cadherin Define Distinct Subclasses of HER2, Luminal B and Triple-negative Breast Cancer
MARIUS RAICA, AMALIA RALUCA CEAUSU, ANCA MARIA CIMPEAN, ŞERBAN COMŞA and SIMONA SARB

Anticancer Research February 2021, 41 (2) 795-802; DOI: https://doi.org/10.21873/anticanres.14831
You have access
Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast Cancer
BENJAMIN NISMAN, TANIR M. ALLWEIS, EINAT CARMON, LUNA KADOURI, BELLA MALY, OFRA MAIMON, AMICHAY MEIROVITZ and TAMAR PERETZ

Anticancer Research February 2021, 41 (2) 949-954; DOI: https://doi.org/10.21873/anticanres.14848
You have access
Transcriptome of Breast Tumors With Different Amplification Status of the Long Arm of Chromosome 8
MARINA K. IBRAGIMOVA, MATVEY M. TSYGANOV, ALINA M. PEVZNER and NIKOLAI V. LITVIAKOV

Anticancer Research January 2021, 41 (1) 187-195; DOI: https://doi.org/10.21873/anticanres.14764
You have access
Dosimetric Impact of Respiratory Motion During Breast Intensity-modulated Radiation Therapy Using Four-dimensional Dose Calculations
YOUNG EUN CHOI, KIHOON SUNG, KAP SANG DONG, HYUN JU KIM and YOUNG-KHI LIM

Anticancer Research January 2021, 41 (1) 417-427; DOI: https://doi.org/10.21873/anticanres.14791

Main menu

User menu

Search

breast cancer

Pages